Even before COVID-19 ravaged the medical workforce, physicians, nurses, and other health workers were at increased risk for burnout and depression. Although these professionals are equipped to manage…
Occupational therapists and occupational therapy (OT) assistants at NYU Langone Health are finding themselves working on the front line of this pandemic to help patients recover from COVID-19.…
NEW YORK (Reuters Health) – Because cholinesterase inhibitors induce can bradycardia, particularly at higher doses, physicians are being urged to closely monitor patients treated with these medications, especially…
NEW YORK (Reuters Health) – Use of erythropoiesis-stimulating agents in US cancer patients undergoing chemotherapy has increased 10-fold since their introduction, yet there’s been no associated decline in…
NEW YORK (Reuters Health) – Lipid assessment of vascular disease risk can be simplified by measuring either cholesterol levels or apolipoproteins, without fasting and without looking at triglyceride…
NEW YORK (Reuters Health) – Adding angioplasty to medical therapy does not improve the outcomes of patients with renal-artery stenosis and carries substantial risks, according to a report…
NEW YORK (Reuters Health) – Keeping hypoxic patients with acute respiratory distress syndrome (ARDS) in the prone position does not reduce mortality, although it might provide a slight…
NEW YORK (Reuters Health) – Long-term ambrisentan therapy safely improves exercise capacity in patients with pulmonary arterial hypertension (PAH), according to results of an extension protocol that followed…
NEW YORK (Reuters Health) – In kidney transplant recipients, bringing hemoglobin levels above 125 g/L with erythropoietin may increase mortality, according to a report in the November 6th…
NEW YORK (Reuters Health) – Exercise-induced ST-segment elevation in patients who never had a myocardial infarction (MI) is a highly specific marker of coronary artery disease and a…
NEW YORK (Reuters Health) – Blood transfusion is safe and may be beneficial in patients with acute decompensated heart failure, say researchers from Israel in the October American…
NEW YORK (Reuters Health) – Giving abciximab to high-risk patients with ST-elevation myocardial infarction (STEMI) before transferring them for percutaneous coronary intervention (PCI) reduces 1-year mortality without increasing…
